Time to reappearance of malaria parasites following various drug treatment regimens in a holoendemic area of western Kenya

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 93, Issue 3, 1999, Pages 304-305

  Shanks, G D ^a,c   Ragama, B O ^b   Oloo, A J ^b  

^a US Army Medical Research Unit Kenya   (Kenya)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c US Military Malaria Vaccine Program   (United States)

Author keywords

Atovaquone proguanil; Chemotherapy; Doxycycline; Halofantrine; Kenya; Malaria; Parasitaemia; Quinine

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; DOXYCYCLINE; HALOFANTRINE; QUININE;

ADULT; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENDEMIC DISEASE; HUMAN; MALARIA; NORMAL HUMAN; PARASITE PREVALENCE; PLASMODIUM; SHORT SURVEY;

CINCHONA PUBESCENS;

EID: 0032787791     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(99)90031-7     Document Type: Article

References (6)

1. Andersen, S. L., Oloo, A. J., Gordon, D. M., Ragama, O. B., Aleman, G. M., Berman, J. D., Tang, D. B., Dunne, M. W. & Shanks, G. D. (1998). Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya. Clinical Infectious Diseases, 26, 146-150.
2. Beier, J. C., Oster, C. N., Onyango, F. K., Bales, J. D., Sherwood, J. A., Perkins, P. V., Chumo, D. K., Koech, D. V., Whitmire, R. E. & Roberts, C. R. (1994). Plasmodium falciparum incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya. American Journal of Tropical Medicine and Hygiene, 50, 529-536.
3. Fairley, N. H. (1947). Sidelights on malaria in man obtained by subinoculation experiments. Transactions of the Royal Society of Tropical Medicine and Hygiene, 40, 621-676.
4. Ohrt, C., Watt, G., Teja Isavadharm, P., Keeratithakul, D., Loesuttiviboon, L., Webster, H. K., Schuster, B. & Fleckenstein, L. (1995). Pharmacokinetics of an extended-dose halofantrine regimen in patients with malaria and in healthy volunteers. Clinical Pharmacology and Therapeutics, 57, 525-532.
5. Shanks, G., Gordon, D. M., Klotz, F. W., Aleman, G. M., Oloo, A. J., Sadie, D. & Scott, T. R. (1998). Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria. Clinical Infectious Diseases, 27, 494-499.
6. Shapiro, T. A., Ranasinha, C. D., Kumar, N. & Barditch-Crovo, P. (1999). Prophylactic activity of atovaquone against Plasmodium falciparum in humans. American Journal of Tropical Medicine and Hygiene, 60, 831-836.